Troponin I Tyrosine Phosphorylation Beneficially Accelerates Diastolic Function.

Area of Science:

• Cardiovascular Research
• Molecular Cardiology
• Biochemistry

Background:

• Heart function is regulated by myofilament protein modifications.
• Tyrosine phosphorylation's role in direct cardiac function modification remains largely unexplored.
• Troponin I (TnI) is a key regulator of cardiac contraction and relaxation, with Y26 phosphorylation potentially influencing relaxation dynamics.

Purpose of the Study:

• To investigate the role of tyrosine phosphorylation of troponin I (TnI) at Y26 in regulating cardiac relaxation.
• To determine if increased TnI-Y26 phosphorylation improves cardiac function in vivo, especially during diastolic dysfunction.

Main Methods:

• In silico prediction and in vitro validation of the TnI-Y26 phosphorylation signaling pathway in cardiomyocytes.
• Development of a TnI-Y26 phosphorylation-mimetic mouse model for in vivo functional assessment.
• Utilized echocardiography, pressure-volume loop analysis, and myofibril mechanics to evaluate cardiac function.
• Assessed the effects of TnI-Y26 phosphorylation in a nephrectomy/DOCA-induced model of diastolic dysfunction.

Main Results:

• Src tyrosine kinase was identified as sufficient to phosphorylate TnI-Y26 in cardiomyocytes.
• TnI-Y26 phosphorylation accelerated in vivo cardiac relaxation without adverse effects on cardiac structure or systolic function.
• Increased TnI-Y26 phosphorylation demonstrated protective benefits in a mouse model of diastolic dysfunction.

Conclusions:

• Tyrosine kinase-mediated phosphorylation of TnI represents a novel mechanism for directly accelerating myocardial relaxation.
• This phosphorylation event beneficially impacts cardiac function in vivo, offering potential therapeutic benefits for diastolic dysfunction.